Camaguey is included as of today in the Phase II clinical trial with the vaccine candidate Mambisa and the Abdala vaccine in COVID-19 convalescents, carried out at the Hermanos Ameijeiras Surgical Clinical Hospital in Havana.

After completing the Ismaelillo clinical trial in this city and analyzing the results, the Center for State Control of Medicines, Equipment and Medical Devices (Cecmed) decided to approve the Authorization for Emergency Use of the Cuban vaccine Abdala for pediatric population in ages between 2 and 11 years. Last week the regulatory entity had authorized the use in the segment between 12 and 18 years.

While the sanitary intervention with the Abdala vaccine continues in the municipalities of Carlos Manuel de Céspedes and Florida, with the first dose, and Camagüey, about to conclude the second, the epidemiological situation in the province of Camagüey worries about its complexity with a rate incidence of COVID-19 of more than 500 cases per 100,000 inhabitants.

A group is waiting, apparently calmly, but it is the most longed-for prick for a long time, especially for them, Health personnel, who have breastfed the pandemic. And although they have had the means to protect themselves, the risk is always there as long as the vaccine or a specific treatment does not exist.